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Abstract
Background: Increasing our understanding of antibiotic resistance mechanisms is critical. To enable progress in
this area, methods to rapidly identify and characterize antibiotic resistance conferring enzymes are required.
Results: We have constructed a sensitive reporter system in Escherichia coli that can be used to detect and
characterize the activity of enzymes that act upon the antibiotic, tetracycline and its derivatives. In this system,
expression of the lux operon is regulated by the tetracycline repressor, TetR, which is expressed from the same
plasmid under the control of an arabinose-inducible promoter. Addition of very low concentrations of tetracycline
derivatives, well below growth inhibitory concentrations, resulted in luminescence production as a result of
expression of the lux genes carried by the reporter plasmid. Introduction of another plasmid into this system
expressing TetX, a tetracycline-inactivating enzyme, caused a marked loss in luminescence due to enzyme-
mediated reduction in the intracellular Tc concentration. Data generated for the TetX enzyme using the reporter
system could be effectively fit with the known Km and kcat values, demonstrating the usefulness of this system for
quantitative analyses.
Conclusion: Since members of the TetR family of repressors regulate enzymes and pumps acting upon almost
every known antibiotic and a wide range of other small molecules, reporter systems with the same design as
presented here, but employing heterologous TetR-related proteins, could be developed to measure enzymatic
activities against a wide range of antibiotics and other compounds. Thus, the assay described here has far-reaching
applicability and could be adapted for high-throughput applications.
Background
Over many decades, a wide variety of in vitro and
in vivo screens have been used to identify small mole-
cules with useful activities, such as antibiotics and
enzyme inhibitors. However, there is still a need for
simple and widely applicable assay systems for charac-
terizing the activity of enzymes against specific small
molecules that avoid the necessity of enzyme purifica-
tion or high level expression. In the work described
here, we have developed an in vivo luminescence-based
reporter system that can be used to detect and charac-
terize enzymatic activities against the antibiotic, Tetracy-
cline (Tc). In the future, systems designed on the same
principle could be used to investigate enzymes active
against a variety of other small molecules.
Tc and its derivatives are highly effective broad specifi-
city antibiotics that have been widely used for many dec-
ades [1]. The ubiquitous utilization of tetracyclines has
resulted in the emergence of numerous resistance
mechanisms mediated by a variety of proteins including
efflux pumps, drug modifying enzymes, and ribosome
protection factors [2]. The significant negative clinical
impact of resistance to tetracyclines has led to intensive
efforts to elucidate the mechanisms of this resistance and
to develop new Tc derivatives that will overcome resis-
tance mechanisms. To this end, much research has
focused on enzymes capable of modifying tetracycline
derivatives, either as a resistance mechanism or as a step
in the tetracycline synthesis process [3]. It is hoped that
characterization of these enzymes will lead to approaches
for combating resistance and creating more potent tetra-
cycline derivatives. Although in vitro spectroscopic meth-
ods are available to assess some enzymatic modifications
of tetracyclines, in vivo assays of these enzymes are quite
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any medium, provided the original work is properly cited.complicated if the enzyme activity does not confer resis-
tance to the growth inhibitory effect of the antibiotic [4].
To aid in characterizing enzymes that modify tetracy-
clines and in identifying novel enzymes active against tet-
racyclines, a simple in vivo method to detect these
activities would be very useful.
In the work presented here, we describe a system for
characterizing tetracycline-modifying enzymes that takes
advantage of the tetracycline repressor (TetR). Many of
the genes conferring resistance to tetracyclines are regu-
lated by TetR, which was first isolated and characterized
more that 25 years ago [5]. TetR is homodimeric with
each monomer composed of an N-terminal DNA-bind-
ing domain, and a C-terminal domain that mediates
dimerization and binds to tetracyclines [6]. In the typical
TetR-regulated regulon, TetR binds to two DNA opera-
tor sites, thereby repressing transcription of its own
gene as well as the divergently transcribed tetA gene,
which encodes an exporter of tetracyclines (Figure 1A).
Binding of tetracyclines to the C-terminal domain of
TetR leads to a conformational change in the DNA-
binding domains, which causes them to lose affinity for
DNA, relieving repression of the tetR and tetA genes.
TetR is the founding member of a huge family of tran-
scriptional regulators, which we refer to as the TetR
family of transcriptional regulators (TFRs). TFRs consti-
tute the third most frequently occurring transcriptional
regulator family found in bacteria [7] with more than
10,000 proteins in the non-redundant protein database
annotated as members of this group. TFRs have been
identified that control the expression of genes conferring
resistance to most known antibiotics including tetracy-
cline, chloramphenicol, erythromycin, ampicillin, and
streptomycin [6]. As well, TFRs are involved in the reg-
ulation of many aspects of bacterial physiology in
response to various small molecule inducers, including
quorum sensing, biofilm formation, morphological dif-
ferentiation and antibiotic production. All characterized
TFRs are homodimers with the same domain structure
and general fold as TetR, and most of them function in
a manner similar to TetR, mediating transcriptional
repression that is relieved only in the presence of their
specific small molecule ligand. TFR sequences in bacter-
ial genomes can be reliably identified due to the high
level of sequence conservation in their N-terminal
DNA-binding domains [6]; however, their ligand-binding
domains display tremendous diversity commensurate
with the broad range of ligands recognized by TFRs.
In a previous study, we designed a TetR-based biosen-
sor that produced luminescence upon addition of tetracy-
cline derivatives [8]. The goals of the work described here
were to improve the sensitivity of this system and to then
exploit it to detect the activities of tetracycline modifying
enzymes. To this end, a TetR regulated transcriptional
promoter was cloned upstream of the lux operon in such
a way that luminescence was elicited at very low concen-
trations of Tc. We then demonstrated that introduction
of the Tc-modifying enzyme, TetX [9], into this system
led to a significant reduction in luminescence due to the
activity of the enzyme, which degrades the inducer of
TetR. This reporter system could be modified to both
identify ligands for TFRs of unknown function, and to
detect enzymes active against these ligands. Since there
are currently at least 50 known ligands for TFRs [6], the
assay principle described here is applicable to the charac-
terization of a considerable number enzymes active
against small molecules.
Results and Discussion
Construction of a Sensitive Luminescence-Based System
for the Detection of Inducing Ligands for Members of the
TetR family of Repressors
We previously constructed a lux-based biosensor system
to investigate the binding of TetR to its DNA binding
A
tetA tetR
O1 O2
tetracycline
TetR
Transporter
B
pYRtetOR
TetR
LuxCDABE
AraC
tetO
pBAD
pETtetX
TetX
T7
Drug
Figure 1 The TetR regulon and pYR cell based repression-
induction system. A) The tetracycline resistance conferring tetR-
tetA regulon. The repressor gene, tetR, is depicted as a dark gray
arrow and the resistance gene, tetA, as a light gray arrow. TetR
regulates the transcription of tetA and its own gene by binding
operators O1 and O2. The binding of TetR to the operator
sequences is inhibited by interaction with Tc. B) Plasmid map of
pYRtetOR and the scheme of the cell based repression-induction
system. TetR expressed from the pBAD promoter on pYRtetOR
represses trancription of the lux genes on the same plasmid. Upon
addition of Tc, TetR is induced, the lux genes are transcribed, and
luminescence is emitted from the cells. If active TetX enzyme is
produced from pETTetX, then the effective concentration of Tc is
reduced by the activity of the enzyme and the transcription level of
the lux genes is also reduced, resulting in decreased luminescence.
The box represents the E. coli cell membrane.
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cited by tetracycline (Tc) and its derivatives [8,10]. For
the work described here, we sought to create a more
sensitive Tc-responsive system. We placed the lux-
CDABE gene cluster under the control of a TetR-repres-
sible promoter on a low copy number pSC101-derived
plasmid [11]. This plasmid, named pYRtetO,m e d i a t e d
production of a high level of luminescence in E. coli
(Figure 2A, white bars), while a plasmid containing the
lux genes with no promoter (pYR) produced no detect-
able luminescence (Figure 2A black bars). TetR was
then cloned into the same plasmid under the control of
the arabinose-inducible pBAD promoter to produce
pYRtetOR (Figure 1B). Expression of TetR in pYRtetOR led
to repression of luminescence (Figure 2A, gray bars)
caused by the binding of TetR to the tetO site in the
promoter of the lux genes. Repression occurred even in
the absence of arabinose, indicating that the small
amount of TetR expression from the pBAD promoter in
the absence of arabinose was sufficient for repression of
lux expression, even though TetR expression could not
be detected by western blot under these conditions.
Addition of arabinose only led to a small reduction in
luminescence (Figure 2B).
To demonstrate the utility of our system for detecting
Tc and its derivatives, luminescence production from
pYRtetOR was measured in the presence of varying con-
centrations of these antibiotics. In these experiments the
degree of induction is expressed as an induction ratio,
the luminescence generated from pYRtetOR divided by
that from pYRtetO ( F i g u r e2 A ,w h i t eb a r s ) .S i g n i f i c a n t
luminescence production was observed at Tc concentra-
tions as low as 1 ng/mL, which is far below its mini-
mum inhibitory concentration (MIC) in E. coli of 500
ng/mL (Figure 2C, white bars) [12]. Anhydrotetracycline
(Atc), a stronger inducer of TetR [13], also displayed a
greater ability to induce TetR in this assay, relieving
repression of the lux operon at a concentration of only
0.1 ng/mL. The addition of 0.02% arabinose to the
system, which greatly increases the intracellular concen-
tration of TetR (Figure 2B), led to a requirement for
much higher concentrations of Tc and Atc, as well as
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Figure 2 Luminescence production by the pYR plasmids in the presence or absence of Tc derivatives. A) Luminescence produced by
pYR, pYRtetO and pYRtetOR harboring cells. B) Degree of repression by TetR at various arabinose concentrations. TetR expression levels are
indicated by an anti-TetR western blot on top of the plot. C) Induction of TetR in pYRtetOR bearing cells at different concentrations of Tc and Atc
in the absence of arabinose. D) TetR induction in pYRtetOR bearing cells induced by different concentrations of Atc, Dox and ClTc in 0.02%
arabinose.
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(ClTc), to relieve lux repression (Figure 2D). For exam-
ple, full induction with Atc under these conditions
required a concentration of 200 ng/mL, indicating that
minimizing the cellular concentration of TetR increases
the sensitivity of the reporter system. Concentrations of
Tc high enough to induce luminescence under condi-
tions of increased TetR expression caused significant
inhibition of cell growth (data not shown). Together,
these data demonstrate that the pYRtetOR system can
detect very low concentrations of Tc and its derivatives.
The reporter system is sensitive to the concentration
and chemical properties of inducer molecules, and to
the intracellular concentration of TetR.
The Detection of Tc-Modifying Enzymatic Activity In Vivo
Using the pYRtetOR Luminescence System
To test the ability of the pYRtetOR system for in vivo
detection of enzymatic activity against Tc, we investi-
gated the TetX enzyme. TetX is an FAD-dependent
monooxygenase from Bacteroides fragilis that has been
shown to hydroxylate Tc creating an unstable com-
p o u n dt h a tu n d e r g o e sr a p i dd e c o m p o s i t i o n[ 9 ] .T o
measure the effect of TetX when expressed in pYRtetOR-
containing cells, we introduced a separate plasmid into
these cells that expressed this enzyme (pETtetX,F i g u r e
1B). For comparison, we also tested pYRtetOR-containing
cells co-transformed with a plasmid expressing the
D311A mutant of TetX (pETtetXD), which is substituted
a tah i g h l yc o n s e r v e dr e s i d u ei nt h eF A D - b i n d i n gs i t e
and was expected to possess no enzymatic activity
(Additional file 1: Figure S1). We verified that the pET-
tetX construct produced active TetX and that the D311A
mutant was reduced in activity using an in vitro fluores-
cence based assay for TetX activity (Additional file1:
F i g u r eS 2 ) .A ss h o w ni nF i g u r e3 A ,w em e a s u r e dt h e
luminescence generated by pETtetX-a n dp E T tetXD-con-
taining cells at varying concentrations of Atc, and found
that considerably less light was emitted by cells contain-
ing the plasmid expressing the WT version of TetX. For
example, pETtetX-bearing cells required a concentration
of ~100 ng/mL Atc to generate a level of luminescence
similar to that emitted from pETtetXD-containing cells at
an Atc concentration of only 2 ng/mL. We surmised
that the reduction in luminescence in pETtetX-containing
cells was the result of TetX-mediated catalysis of Atc
into an unstable product and/or a product that could no
longer bind TetR. Thus, the concentration of Atc avail-
able within the cells to bind TetR was decreased, which
led to a greater degree of transcriptional repression of
the lux genes by TetR (Figure 1B). We found that a
similarly large reduction of luminescence was elicited by
pETtetX when the assay was done under conditions of
high TetR expression (0.02% arabinose) even though
induction did not occur until a much higher concentra-
tion of Atc was added (Figure 3B). Assays performed
with Dox and ClTc indicated that, as expected [9], TetX
was also active against these Tc derivatives since
reduced luminescence was observed in pETtetX-contain-
ing cells treated with these compounds (Figures 3C, D).
It should be noted that the expression levels of WT
TetX and TetX-D311A were similar (Figure 3E), indicat-
ing that the luminescence differences observed above
were due to differences in the activity of these enzymes.
Similar reductions in luminescence were observed when
cells were treated with Tc (data not shown).
Quantitative Analysis of the In Vivo TetX Assay
Our success in detecting the enzymatic activity of TetX
in a cell based assay prompted us to determine whether
the behavior observed in our assays could be accounted
for by the known kinetic parameters of the TetX
enzyme. To this end we formulated a series of equations
to describe the TetX enzymatic activity within the cell
based system in terms that were as simple as possible
(see Methods for details). The objective of our analysis
was to account for the difference between the dose-
response curves generated in the presence of TetX as
compared to TetXD311A, which we showed above is an
inactive enzyme. Our equations were predicated on the
assumption that once tetracycline is added, the media
becomes an infinite drug reservoir. In the absence of
TetX, drug molecules enter cells from the media driven
by diffusion and rapidly reach an effective steady state
concentration, which is referred to as [Ieff]. With TetX
present inside the cell, the intracellular concentration of
drug is simultaneously increased by the process of diffu-
sion and decreased by the enzymatic activity of TetX.
The intracellular drug concentration reaches equilibrium
only when the rate of inward diffusion is matched by
the rate of enzymatic modification. Thus, the final effec-
tive concentration of drug within these cells ([Ieff]) is a
function not only of the extracellular concentration of
drug ([Iout]), but also the rate of drug diffusion, the
enzymatic activity of TetX, and the time taken after
drug addition for the intracellular drug concentration to
reach equilibrium (t).
In our data fitting, the enzymatic activity of TetX on
Dox and ClTc was modeled by entering the known in
vitro Km and kcat values of TetX for these compounds as
fixed parameters [9]. The only free parameter in the fit-
ting process was an arbitrary diffusion constant, K that
accounted for the diffusion properties of Tc derivatives.
Although parameters for the diffusion of Tc into E. coli
have been experimentally determined [14,15], the value
of K for our fitting could not be determined ap r i o r i
because it is not known how the diffusional properties
of Tc derivatives would change upon modification by
Yu et al. BMC Biochemistry 2010, 11:34
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Page 4 of 10TetX or how quickly the modified Tc derivatives might
degrade within the cell. In fitting the data from each
experiment, the data generated for TetXD311A was used
as a reference to predict how much luminescence would
be generated at a given effective concentration of drug
in the absence of enzyme. It can be seen in Table 1 that
we were able to fit the Dox and ClTc data effectively
using the known kinetic parameters of TetX (R
2 values
equaled 0.90 and 0.66 for Dox and ClTc, respectively).
To fit the curves generated using Atc, for which Km and
kcat values for TetX were not known, we allowed Km
and kcat to also be free parameters. Notably, we were
still able to obtain good fits to our data and the para-
meters returned were similar to those in the other fits.
These data suggest that TetX acts on Atc with similar
kinetic parameters as on Dox and ClTc. The ability to
obtain fits to different experiments with consistent
enzyme parameter values supports our conclusion that
the behavior of this system is the result of the enzymatic
activity of TetX against Tc derivatives. The use of the
data generated from the pETtetXD-containing cells as the
reference curve requires that the time taken after drug
addition for the intracellular drug concentration to
reach equilibrium in pETtetX-containing cells (t) is short
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Figure 3 Activities of TetX detected using the pYRtetOR system and fluorescence-based assays. A-D) Induction ratios in the presence of
the active enzymes (open circles) or mutated inactive enzymes (solid circles). Best fit lines using the enzyme kinetics model (see text and
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cell pellet, and the TetR bands show the amount of 6xHis tagged protein from 1 μL solution containing the indicated concentration protein.
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Page 5 of 10enough to not affect luminescence accumulation. With
the enzyme parameters from the above data fitting, we
were also able to estimate t (see Methods for details).
A ss h o w ni nT a b l e1 ,t w a sl e s st h a n1 0m i ni na l l
experiments, which is much shorter than the time at
which luminescence was measured (2-4 hours).
Conclusions
In the work described here we have developed a sensi-
tive luminescence-based in vivo assay to detect enzy-
matic activity against tetracyclines. Our assay system is
based on the ability of these compounds to induce TetR
regulated transcription and the diminution of this
induction that occurs when a Tc modifying enzyme
activity is present within the cell. An important aspect
of this system is that it not only detects enzyme activity,
but also allows quantitation of this activity. The only
requirement is that the Tc derivative is modified in a
way that lowers its affinity for TetR. Of course, our sys-
tem will fail to detect an enzyme activity if the modifica-
tion produced does not change the affinity of the Tc
derivative for TetR. However, due to the sensitivity of
our assay system and the use of titrations to detect
activity, even a small change in affinity would be
detected. In addition, there are a number of TetR
mutants with varying reactivities towards different Tc
derivatives [16,17] that could be utilized in our assay
system to maximize the number of Tc modifications
that could be detected. Finally, there are other TetR-like
repressors that are induced by Tc derivatives and at
least one of these, TtgR of Pseudomonas putida [18],
binds to Tc by a completely different mechanism com-
pared to TetR. By using these different repressors, a
wide range of modifications of tetracyclines would likely
be detectable. Since there is great interest in the identifi-
cation of enzymes that may modify tetracyclines to pro-
duce more potent antibiotics [19], our assay could be
useful as a rapid screen to determine the level of activity
of a given enzyme against a range of tetracyclines.
Because of the wide range of ligands bound by TFRs [6],
the assay system described here could be adapted to test
for enzymatic activities against a huge variety of antibio-
tics and other small molecules. Supporting the general
utility of our system, we have constructed reporters
analogous to pYRtetOR for 22 diverse TFRs, and all of
these TFRs are able to repress transcription of the lux
operon when expressed in E. coli (data not shown).
Ar e p o r t e rs i m i l a rt ot h eo n ed e s c r i b e dh e r ew a su s e d
to discover new ligands for the ActR repressor of S. coe-
licolor [20,21]. Future studies will determine whether
enzyme activities for a variety of small molecules will be
detectable using these systems. It should be noted that
the same principles used to design this TetR-based
system could be used for any of the other families of
transcriptional regulators that are induced by small
molecules.
In general, our TetR-based system or other systems
designed in a similar manner present many advantages
for investigation of enzymes with activities against small
molecules. First, we are able to detect enzyme activity
using only nanogram quantities of compound. This fea-
ture could be critical in screening for activities against
compounds that are available only in small quantities as
in the case of compound libraries used for high-
throughput screening. The ability to modulate the
expression level of the repressor in our system by addi-
tion of varying concentrations of arabinose allows the
intracellular repressor concentration to be adjusted to a
level at which there is just enough present to repress
transcription. Consequently, addition of only a small
amount of inducer is required for derepression of the
system. A second advantage of our system is that it pro-
vides the potential to investigate enzymatic activities
without having to purify the enzymes or know their co-
factor requirements. Our assay system would be equally
capable of measuring the activity of difficult to purify
membrane proteins, such as drug efflux pumps. TetR-
based reporter systems have been shown to function in
aw i d er a n g eo fc e l lt y p e si ncluding mammalian cells
[22-24], thus, enzymatic assays operating by the same
principle as ours could be adapted to many cell types.
A final advantage of our system is that it could be used
to screen for enzymes with activity against a given com-
pound of interest. For this purpose, a library of plasmids
expressing candidate enzymes would be transformed
into a strain containing a pYR-derivative that responded
to the compound of interest. Individual colonies could
then be screened in a 96-well format for reduced
Table 1 Fitting results of cell based TetX activity experiments
a
Enzyme Experiment Substrate R
2 Km (μM) kcat (s
-1) [Enzyme] (μM) K (10
-3) t (s)
TetX Figure 3A Atc 0.90 130 0.7 15 3.5 37
TetX Figure 3B Atc 0.96 160 0.4 15 12.2 41
TetX Figure 3C Dox 0.90 83 0.6 15 6.9 27
TetX Figure 3D ClTc 0.66 110 0.3 15 2.9 70
a Fixed parameters were shown in regular fonts and values returned from fitting were shown in bold italic fonts
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that modified the TFR-binding molecule. In this way, it
will be possible to systematically identify novel enzymes
with activities against many important small molecules.
Methods
Bacterial strains, plasmid constructs and culture
conditions
Bacterial strains and plasmids used in this work are
s h o w ni nA d d i t i o n a lf i l e 1 :T a b l eS 1 .E. coli cells were
grown at 37°C in Luria broth (LB) or LB agar medium
containing the following antibiotics when necessary:
kanamycin (50 μg/mL), ampicilin (100 μg/mL) and
streptomycin (50 μg/mL). Protein expression for purifi-
cation and E. coli drug susceptibility assays were carried
out in E. coli BL21*(DE3). In vivo repression and induc-
tion assays were performed using E. coli Top10 (Invitro-
gen) because it is an arabinose metabolism deficient
strain and produces more luminescence than BL21*
(DE3). A T7 polymerase bearing E. coli Top10 (DE3)
strain was constructed for the in vivo enzymatic activity
assay using the Lambda DE3 Lysogenization Kit from
Novagen.
DNA manipulation procedures
Standard procedures were employed for all DNA manip-
ulation and molecular cloning [25]. The oligonucleotides
and primers used in this study were synthesized from
the ACGT Corporation (Toronto) and listed in Addi-
tional file1: Table S2. PCR reactions were carried out
using Vent DNA polymerase (New England Biolabs).
The QuikChange site-directed mutagenesis protocol
(Stratagene) was employed to create point mutations of
TetX.
Construction of the pYR plasmids and protein expression
vectors
The pCS26-Pac plasmid [11], which contains the lux-
CDABE operon on a low copy number pSC101-derived
vector [26], was modified by inserting a double stranded
oligonucleotide (oligo YLuxupdateF annealed to oligo
YLuxupdateR) upstream of luxCDABE operon in
between XhoIa n dBamHI sites. The araBAD promoter
and the araC gene from the pBAD vector (Invitrogen),
were amplified using primers SR204 and SR205 and
then ligated into the EcoRI and KpnI restriction sites
introduced as described above, creating the pYR plasmid
(~13 kbp). A synthetic promoter consisting of the TetR
operator and promoter tetO from the Tn10 tetA promo-
ter region was prepared by annealing YZ201 and YZ202
oligonucleotides. This promoter was then introduced
into pYR between KpnIa n dPmlI upstream of the lux-
CDABE cluster to give pYRtetO.T h etetR gene was
amplified from pETtetR [27] using primer YZ203 and
Y Z 2 0 4a n dc l o n e di n t op Y R tetO between XhoIa n d
EcoRI, downstream of the araBAD promoter, to give
pYRtetOR. Expression vector pETtetX was prepared by
introducing the PCR amplified tetX gene using primer
pair YZ241-2 YZ242 into pET21 between EcoRI and
XhoI sites.
Luminescence assays
For the repression and induction assays, isolated E. coli
colonies were used to inoculate 2 mL cultures, which
were grown overnight. 10 μL of overnight culture was
added into 2 mL of LB media in the presence of varying
concentrations of arabinose and drugs. These cultures
were grown for 12 to 16 h before measurement of lumi-
nescence using a BMG Fluostar OPTIMA luminometer.
In the enzyme assays, we inoculated 4 μL overnight cul-
tures into 200 μL fresh pH 7 buffered LB media con-
taining 0.04% glycerol, then grew for 2-4 h until early
log phase and added varying concentrations of drugs.
Luminescence and optical density were measured every
15 min using a TECAN Infinite M200 luminometer.
Luminescence from similar early stationary phase cells
(around 2-4 h after drug induction) was used to calcu-
late the induction ratio. Multiple replicates (N > = 2)
were performed and the 95% confidence intervals which
are 1.96 times standard errors were displayed as error
bars.
Enzyme Kinetics Data Fitting for Enzyme-Containing Cells
In the presence of TetX, the effective cytoplasmic indu-
cer concentration, [Ieff] was expected to reach steady
state when the enzyme catalytic rate equalled the diffu-
sion rate. The enzyme catalytic rate was expressed using
the Michaelis-Menten equation:
vk E
I
KI
tc a t
eff
me f f
=⋅ ⋅
+
[]
[]
[]
(1)
where vt is the rate of reaction at time point t after
inducer addition with an intracellular inducer concen-
tration of [Ieff]a tt h a tt i m ep o i n t ,kcat is the catalytic
rate constant, Km is the Michaelis constant and [E]i s
the enzyme concentration, which was assumed to be
constant. The concentration of enzyme was estimated
through analysis of Western Blots (see below). To deter-
mine [Ieff] as a function of the extracellular inducer con-
centration ([Iout]), the diffusion process across the cell
membranes was modeled. Diffusion is normally
described by the Fick’s first law of diffusion:
vP A I I do u t e f f =⋅⋅ − 00 [] (2)
where vd is the diffusion rate, P0 is the permeability
coefficient through diffusion barrier, and A0 is the
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Tc [28], to simplify the model and generalize it to situa-
tions where P0 and A0 might not be known for a given
compound, we replaced these parameters with an arbi-
trary diffusion constant K. The diffusion process was
then expressed by:
vK I I do u t e f f =⋅ − [] (3)
K accounts for not only P0 and A0, but also the diffu-
sion-effective concentration difference across the cell
membranes. Since enzymes may only make subtle
changes on the inducer, it is impossible to predict how
these changes would affect diffusion properties. In addi-
tion, some enzymatic modifications will lead to inducer
degradation. In the steady state, vt equals to vd,t h e r e -
fore the inducer concentration [Ieff] could be determined
by solving:
kE
I
KI
KI I
I
kE K
cat
eff
me f f
out eff
eff
cat
⋅⋅
+
=⋅ − ⇒
=
−⋅
[]
[]
[]
[]
[]
([ ] / − −++ ⋅ −+ + ⋅ ⋅ [] ) ( [ ] / [] ) [] IK k E K IK K I out m cat out m m out
2 4
2
(4)
Thus, the steady state [Ieff] can be described as a func-
tion of three parameters: K, Km and kcat.T h er e l a t i o n -
ship between [Ieff] and the luminescence induction ratio
(L) was determined from curves generated for pETtetXD-
containing cells, which were assumed to contain no
active TetX. In this situation, the steady state [Ieff]a n d
[Iout] were assumed to be equivalent. While this may
not be strictly true in all conditions (in fact, the intracel-
lular concentration of Tc has actually been found to be
4-fold higher than the extracellular concentration under
some conditions [15]), the success of our fitting proce-
dure requires only that [Ieff]a n d[ Iout]a r er e l a t e db ya
constant value over the range of inducer concentrations
used. Any deviation from equivalence of [Ieff]a n d[ Iout]
is accounted for in the K value described above, which
is a free parameter in our fitting scheme. The curves of
L versus [Iout]f o rt h ep E T tetXD-containing cells were fit
to a hyperbolic equation (in the presence of 0.0002%
arabinose) or a sigmoidal model (in the presence of
0.02% arabinose) as shown:
L
aI
bI
cI out
out
out =
⋅
+
+⋅
[]
[]
[] (5)
LL
aI
cI
out
b
b
out
b =+
⋅
+⋅
0
[]
[]
(6)
where a, b, c and L0, are arbitrary parameters giving
the completed standard curves. Although these equa-
t i o n sh a v en op h y s i c a lr e l e v a n c et ot h ef u n c t i o n i n go f
the system, they accurately captured the relationship
between L and [Iout] under these conditions (R
2 >0 . 9i n
every fitting). Finally the L versus [Iout]c u r v e sf o rp E T -
tetX-containing cells were fitted to the following equa-
tions using the information derived from the fits of the
pETtetXD-containing cells.
Under 0.0002% arabinose:
L
aI
bI
cI I I
aI
bI
out
out
out out s
eff
eff
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⋅
+
+⋅ ≤
⋅
+
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[] , [] [ ]
[]
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cI I I eff out s
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Under 0.02% arabinose:
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(8)
The equations above also took into account the com-
petition for drugs from TetR. Since TetR binds Tc deri-
vatives much more tightly than TetX, TetX will only
induce when TetR is saturated. The TetR saturating
inducer concentration [Is] was set to be the inducer con-
centration corresponding to the onset of luminescence
induction. For fitting curves to data derived from pET-
tetX-containing cells in response to Dox and ClTc, only
the K value was left as free parameters and published in
vitro Km and kcat values were used.
The steady state [Ieff] can also be expressed as a func-
tion of the equilibration time t:
[] ( ) Iv v t d t eff d t
t
=− ⋅ ∫0
(9)
where vd was determined from equation (3) and vt was
determined from equation (1). With K, Km and kcat
determined in previous steps, t became the only free
p a r a m e t e ra n dc a nb er e t u r n e db yd a t af i t t i n gu s i n g
equation (7) or (8).
Estimation of Intracellular Enzyme Concentrations
To estimate in vivo enzyme concentrations, TetX-bear-
ing cells were harvested at the time when drugs were
added to induce luminescence. Approximately 1 μLc e l l
pellet was lysed and loaded on a SDS-PAGE and sub-
jected to a Western blot using anti-6xHis antibody. A
series of purified 6xHis tagged TetR was loaded on the
same gel as concentration standards (Figure 3E). TetX
was estimated to be 15 μM.
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enzymes
Proteins were expressed as C-terminal hexahistidine
fusions in E. coli strain BL21*(DE3) using plasmids
derived from pET21d (Novagen). TetR was purified as
previously described [27]. For TetX and mutants, cells
bearing pETtetX w e r eg r o w na t3 0 ° Ct oa nO D 600 of
0.8, induced with 1 mM IPTG, and the grown over-
night at 20°C. Cells were harvested and lysed in 6 M
GuHCl. Protein was purified using nickel affinity chro-
matography by the denatured protein procedure (Qia-
gen). TetX was refolded by dialyzing into 10 mM Tris-
HCl (pH 8.0), 50 mM NaCl, 0.1 mM EDTA, 1 mM
DTT and 2% glycerol. These proteins were further
purified through a hi-load sephadex-75 gel filtration
column (Pharmacia) using a Pharmacia LKB FPLC. All
in vitro protein assays were performed in the dialysis
buffer described above.
In vitro enzymatic assays
Fluorescence assays were performed using an Aviv ATF
105 spectrofluorometer in a 1 cm path length cuvette.
Complex solutions with the indicated concentration of
ingredients were excited at 340 nm and emission
between 350 and 600 nm was recorded over time, aver-
aging for 2 seconds at each wavelength.
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